AstraZeneca Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	12,402	8,691	6,899	2,501	-265
Depreciation & Amortization	5,733	6,688	5,387	5,480	6,530
Other Adjustments	1,738	1,438	1,206	542	141
Change in Receivables	-1,728	-1,624	-1,425	-1,349	-961
Changes in Inventories	-755	-131	-669	3,941	1,577
Changes in Accounts Payable	1,346	862	2,394	1,165	1,405
Changes in Income Taxes Payable	-2,845	-2,750	-2,366	-1,623	-1,743
Changes in Other Operating Activities	-1,316	-1,313	-1,081	-849	-721
Operating Cash Flow	14,575	11,861	10,345	9,808	5,963
Operating Cash Flow Growth	22.88%	14.65%	5.47%	64.48%	24.25%
Capital Expenditures	-2,810	-1,924	-1,361	-1,091	-1,091
Sale of Property, Plant & Equipment	13	55	132	282	13
Purchases of Intangible Assets	-3,095	-2,662	-2,417	-1,480	-1,109
Proceeds from Sale of Intangible Assets	136	123	291	447	587
Purchases of Investments	-229	-96	-136	-45	-184
Proceeds from Sale of Investments	131	108	129	-72	105
Payments for Business Acquisitions	-1,230	-3,782	-1,099	-1,035	-10,117
Other Investing Activities	276	198	397	34	738
Investing Cash Flow	-6,808	-7,980	-4,064	-2,960	-11,058
Long-Term Debt Issued	-	6,492	3,816	-	12,929
Long-Term Debt Repaid	-2,029	-4,652	-4,942	-1,271	-4,759
Net Long-Term Debt Issued (Repaid)	-2,029	1,840	-1,126	-1,271	8,170
Issuance of Common Stock	40	38	33	29	29
Repurchase of Common Stock	-	-521	-81	-	-
Net Common Stock Issued (Repurchased)	40	-483	-48	29	29
Common Dividends Paid	-4,858	-4,613	-4,500	-4,491	-3,885
Other Financing Activities	-8	-1,180	-1,157	-1,090	-665
Financing Cash Flow	-6,855	-4,436	-6,831	-6,823	3,649
Effect of Exchange Rate Changes on Cash and Cash Equivalents	46	-93	-60	-80	-62
Net Cash Flow	223	-115	-286	25	-1,446
Free Cash Flow	11,765	9,937	8,984	8,717	4,872
Free Cash Flow Growth	18.40%	10.61%	3.06%	78.92%	26.94%
FCF Margin	20.03%	18.38%	19.61%	19.65%	13.02%
Free Cash Flow Per Share	3.77	3.18	2.88	2.79	1.71
Levered Free Cash Flow	7,549	10,307	7,133	9,040	14,239
Unlevered Free Cash Flow	10,692	9,536	9,383	11,970	5,499

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.